879 related articles for article (PubMed ID: 28143836)
1. Periodontitis in early and chronic rheumatoid arthritis: a prospective follow-up study in Finnish population.
Äyräväinen L; Leirisalo-Repo M; Kuuliala A; Ahola K; Koivuniemi R; Meurman JH; Heikkinen AM
BMJ Open; 2017 Jan; 7(1):e011916. PubMed ID: 28143836
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Periodontal Disease and Periodontopathic Bacteria in Anti-Cyclic Citrullinated Protein Antibody-Positive At-Risk Adults Without Arthritis.
Mankia K; Cheng Z; Do T; Hunt L; Meade J; Kang J; Clerehugh V; Speirs A; Tugnait A; Hensor EMA; Nam JL; Devine DA; Emery P
JAMA Netw Open; 2019 Jun; 2(6):e195394. PubMed ID: 31173126
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory biomarkers in saliva and serum of patients with rheumatoid arthritis with respect to periodontal status.
Äyräväinen L; Heikkinen AM; Kuuliala A; Ahola K; Koivuniemi R; Laasonen L; Moilanen E; Hämäläinen M; Tervahartiala T; Meurman JH; Leirisalo-Repo M; Sorsa T
Ann Med; 2018 Jun; 50(4):333-344. PubMed ID: 29683364
[TBL] [Abstract][Full Text] [Related]
4. Activity of rheumatoid arthritis correlates with oral inflammatory burden.
Äyräväinen L; Heikkinen AM; Kuuliala A; Ahola K; Koivuniemi R; Peltola J; Suomalainen A; Moilanen E; Hämäläinen M; Laasonen L; Meurman JH; Leirisalo-Repo M
Rheumatol Int; 2018 Sep; 38(9):1661-1669. PubMed ID: 30043237
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and severity of periodontitis in Indonesian patients with rheumatoid arthritis.
Susanto H; Nesse W; Kertia N; Soeroso J; Huijser van Reenen Y; Hoedemaker E; Agustina D; Vissink A; Abbas F; Dijkstra PU
J Periodontol; 2013 Aug; 84(8):1067-74. PubMed ID: 23075431
[TBL] [Abstract][Full Text] [Related]
6. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis.
Mikuls TR; Payne JB; Yu F; Thiele GM; Reynolds RJ; Cannon GW; Markt J; McGowan D; Kerr GS; Redman RS; Reimold A; Griffiths G; Beatty M; Gonzalez SM; Bergman DA; Hamilton BC; Erickson AR; Sokolove J; Robinson WH; Walker C; Chandad F; O'Dell JR
Arthritis Rheumatol; 2014 May; 66(5):1090-100. PubMed ID: 24782175
[TBL] [Abstract][Full Text] [Related]
7. Periodontal treatment decreases levels of antibodies to Porphyromonas gingivalis and citrulline in patients with rheumatoid arthritis and periodontitis.
Okada M; Kobayashi T; Ito S; Yokoyama T; Abe A; Murasawa A; Yoshie H
J Periodontol; 2013 Dec; 84(12):e74-84. PubMed ID: 23701010
[TBL] [Abstract][Full Text] [Related]
8. The role of risk factors for periodontal disease in patients with rheumatoid arthritis.
Gleissner C; Willershausen B; Kaesser U; Bolten WW
Eur J Med Res; 1998 Aug; 3(8):387-92. PubMed ID: 9707521
[TBL] [Abstract][Full Text] [Related]
9. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults.
Kobayashi T; Murasawa A; Komatsu Y; Yokoyama T; Ishida K; Abe A; Yamamoto K; Yoshie H
J Periodontol; 2010 May; 81(5):650-7. PubMed ID: 20429644
[TBL] [Abstract][Full Text] [Related]
10. Periodontitis and Porphyromonas gingivalis in preclinical stage of arthritis patients.
Hashimoto M; Yamazaki T; Hamaguchi M; Morimoto T; Yamori M; Asai K; Isobe Y; Furu M; Ito H; Fujii T; Terao C; Mori M; Matsuo T; Yoshitomi H; Yamamoto K; Yamamoto W; Bessho K; Mimori T
PLoS One; 2015; 10(4):e0122121. PubMed ID: 25849461
[TBL] [Abstract][Full Text] [Related]
11. Cross-Sectional Evaluation of Periodontal Status and Microbiologic and Rheumatoid Parameters in a Large Cohort of Patients With Rheumatoid Arthritis.
Schmickler J; Rupprecht A; Patschan S; Patschan D; Müller GA; Haak R; Mausberg RF; Schmalz G; Kottmann T; Ziebolz D
J Periodontol; 2017 Apr; 88(4):368-379. PubMed ID: 27858553
[TBL] [Abstract][Full Text] [Related]
12. Serum Immunoglobulin G Levels to Porphyromonas gingivalis Peptidylarginine Deiminase Affect Clinical Response to Biological Disease-Modifying Antirheumatic Drug in Rheumatoid Arthritis.
Kobayashi T; Ito S; Kobayashi D; Shimada A; Narita I; Murasawa A; Nakazono K; Yoshie H
PLoS One; 2016; 11(4):e0154182. PubMed ID: 27111223
[TBL] [Abstract][Full Text] [Related]
13. Anti-rheumatic medication and salivary MMP-8, a biomarker for periodontal disease.
Äyräväinen L; Heikkinen AM; Kuuliala A; Ahola K; Koivuniemi R; Moilanen E; Hämäläinen M; Tervahartiala T; Meurman JH; Leirisalo-Repo M; Sorsa T
Oral Dis; 2018 Nov; 24(8):1562-1571. PubMed ID: 29969841
[TBL] [Abstract][Full Text] [Related]
14. Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis.
Arvikar SL; Collier DS; Fisher MC; Unizony S; Cohen GL; McHugh G; Kawai T; Strle K; Steere AC
Arthritis Res Ther; 2013; 15(5):R109. PubMed ID: 24017968
[TBL] [Abstract][Full Text] [Related]
15. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
[TBL] [Abstract][Full Text] [Related]
16. Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients.
Ceccarelli F; Orrù G; Pilloni A; Bartosiewicz I; Perricone C; Martino E; Lucchetti R; Fais S; Vomero M; Olivieri M; di Franco M; Priori R; Riccieri V; Scrivo R; Shoenfeld Y; Alessandri C; Conti F; Polimeni A; Valesini G
Clin Exp Immunol; 2018 Nov; 194(2):244-252. PubMed ID: 30009382
[TBL] [Abstract][Full Text] [Related]
17. Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study.
de Smit M; Westra J; Vissink A; Doornbos-van der Meer B; Brouwer E; van Winkelhoff AJ
Arthritis Res Ther; 2012 Oct; 14(5):R222. PubMed ID: 23075462
[TBL] [Abstract][Full Text] [Related]
18. Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis.
Hashimoto T; Yoshida K; Hashimoto N; Nakai A; Kaneshiro K; Suzuki K; Kawasaki Y; Shibanuma N; Hashiramoto A
Int J Rheum Dis; 2017 Jun; 20(6):722-730. PubMed ID: 27943573
[TBL] [Abstract][Full Text] [Related]
19. Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.
Rannio T; Asikainen J; Hannonen P; Yli-Kerttula T; Ekman P; Pirilä L; Kuusalo L; Mali M; Puurtinen-Vilkki M; Kortelainen S; Paltta J; Taimen K; Kauppi M; Laiho K; Nyrhinen S; Mäkinen H; Isomäki P; Uotila T; Aaltonen K; Kautiainen H; Sokka T
Scand J Rheumatol; 2017 Nov; 46(6):425-431. PubMed ID: 28367663
[TBL] [Abstract][Full Text] [Related]
20. Effects of Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Response to Periodontal Treatment in Patients with Rheumatoid Arthritis.
Jung GU; Han JY; Hwang KG; Park CJ; Stathopoulou PG; Fiorellini JP
Biomed Res Int; 2018; 2018():1465402. PubMed ID: 30211216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
